Keyphrases
Microtubules
100%
Streptozotocin-induced Diabetes
100%
Chemical Depolymerization
100%
Myocytes
57%
Colchicine
42%
Diabetic
28%
Diabetic Cardiomyopathy
28%
Sarcomere Length
28%
Type I Diabetes
14%
Pathological Conditions
14%
Microtubule Disruptors
14%
After Injection
14%
Ventricular Myocytes
14%
Cardiac Dysfunction
14%
Time to Peak
14%
Streptozotocin
14%
Vascular Disease
14%
Type 1 Diabetes Mellitus (T1DM)
14%
Stable Microtubules
14%
Immunofluorescence Microscopy
14%
Diabetic Animals
14%
Microtubule Cytoskeleton
14%
Diabetic Rats
14%
Microtubule Disruption
14%
Pharmacology, Toxicology and Pharmaceutical Science
Streptozotocin-Induced Diabetes Mellitus
100%
Colchicine
100%
Diabetes Mellitus
66%
Diabetic Cardiomyopathy
66%
Vascular Disease
33%
Streptozotocin
33%
Insulin Dependent Diabetes Mellitus
33%
Confocal Microscopy
33%